Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | N/A | 221 |
| Other Working Capital | N/A | N/A | N/A | N/A | -169 |
| Other Operating Activity | 0 | 0 | 0 | 0 | -672 |
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $-620 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | 8 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $8 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -11 |
| Beginning Cash Position | N/A | N/A | N/A | N/A | 2,969 |
| End Cash Position | N/A | N/A | N/A | N/A | 2,346 |
| Net Cash Flow | $N/A | $N/A | $N/A | $N/A | $-623 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | N/A | N/A | -620 |
| Free Cash Flow | 0 | 0 | 0 | 0 | -620 |